Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

US Patent 6524347 · Granted Feb 25, 2003

Estimated economic value: $3,259,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Caspase inhibitors and methods of use thereof2024
Caspase inhibitors and methods of use thereof2023
(S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluoro2022
Highly water-soluble salts of a short acting phenylalkylamine calcium channel bl2018
Short acting phenylalkylamine calcium channel blockers and uses thereof2018
Short acting phenylalkylamine calcium channel blockers and uses thereof2018
Short acting phenylalkylamine calcium channel blockers and uses thereof2018
Short acting phenylalkylamine calcium channel blockers and uses thereof2017
Short acting phenylalkylamine calcium channel blockers and uses thereof2016
Short acting phenylalkylamine calcium channel blockers and uses thereof2016
Short acting benzothiazepine calcium channel blockers and uses thereof2013
Ligands for monoamine receptors and transporters, and methods of use thereof2010